The Arginine Deiminase Operon Is Responsible for a Fitness Trade-Off in Extended-Spectrum-β-Lactamase-Producing Strains of Escherichia coli | Zendy

Typhaine BillardPomares | Zendy; Olivier Clermont | Zendy; Miguel Sautié Castellanos | Zendy; Fatma Magdoud | Zendy; Guilhem Royer | Zendy; Bénédicte Condamine | Zendy; Stéphanie Fouteau | Zendy; Valérie Barbe | Zendy; David Roche | Zendy; Stéphane Cruveiller | Zendy; Claudine Médigue | Zendy; Dominique Pognard | Zendy; Jérémy Glodt | Zendy; Sara Dion | Zendy; Odile Rigal | Zendy; Bertrand Picard | Zendy; Érick Denamur | Zendy; Catherine Branger | Zendy

Open Access

The Arginine Deiminase Operon Is Responsible for a Fitness Trade-Off in Extended-Spectrum-β-Lactamase-Producing Strains of Escherichia coli

Author(s) -

Typhaine BillardPomares,

Olivier Clermont,

Miguel Sautié Castellanos,

Fatma Magdoud,

Guilhem Royer,

Bénédicte Condamine,

Stéphanie Fouteau,

Valérie Barbe,

David Roche,

Stéphane Cruveiller,

Claudine Médigue,

Dominique Pognard,

Jérémy Glodt,

Sara Dion,

Odile Rigal,

Bertrand Picard,

Érick Denamur,

Catherine Branger

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00635-19

Subject(s) - operon , escherichia coli , arginine deiminase , microbiology and biotechnology , enterobacteriaceae , arginine , biology , beta lactamase , gene , chemistry , genetics , amino acid

We previously identified an operon involved in an arginine deiminase (ADI) pathway (arc operon) on a CTX-M-producing plasmid from an O102-ST405 strain ofEscherichia coli . As the ADI pathway was shown to be involved in the virulence of various Gram-positive bacteria, we tested whether the ADI pathway could be involved in the epidemiological success of extended-spectrum-β-lactamase (ESBL)-producingE. coli strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research